Literature DB >> 7504584

Growth factors and angiogenesis.

R J Schott1, L A Morrow.   

Abstract

The list of growth factors with angiogenic potential is growing. It is not clear why so many factors with angiogenic potential exist, although Folkman postulated that this apparent redundancy is indicative of the essential nature of the angiogenic response. Additionally, these factors or their close relatives have other biological activities, including developmental morphogenesis, tumourigenesis, regeneration of injured tissue, and immunosignalling. Recent advances in the understanding of these factors include primary peptide sequence for all but one peptide growth factor included in this review, identification of cell surface receptors for many, and extensive characterisation of biological potential. Despite the torrent of data on angiogenic growth factors in the last decade, the chasm between form and physiology remains formidable.

Mesh:

Substances:

Year:  1993        PMID: 7504584     DOI: 10.1093/cvr/27.7.1155

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  10 in total

1.  Kawasaki disease on PDGF expression and VSMC proliferation.

Authors:  H Wang; H Wang; P Cheng
Journal:  J Tongji Med Univ       Date:  1998

2.  Study on angiogenesis factor of human osteosarcoma.

Authors:  H Wu; T Wang; Z Deng; D Chen
Journal:  J Tongji Med Univ       Date:  2000

3.  Angiogenesis at the site of neuroma formation in transected peripheral nerve.

Authors:  D W Zochodne; C Nguyen
Journal:  J Anat       Date:  1997-07       Impact factor: 2.610

4.  Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase.

Authors:  H A Kim; B Ling; N Ratner
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

Review 5.  Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects.

Authors:  E J Battegay
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

6.  VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population.

Authors:  Paolo Maltese; Emanuele Canestrari; Annamaria Ruzzo; Francesco Graziano; Alfredo Falcone; Fotios Loupakis; Giuseppe Tonini; Daniele Santini; Mauro Magnani
Journal:  Int J Colorectal Dis       Date:  2008-10-02       Impact factor: 2.571

7.  High-resolution harmonics ultrasound imaging for non-invasive characterization of wound healing in a pre-clinical swine model.

Authors:  Surya C Gnyawali; Kasturi G Barki; Shomita S Mathew-Steiner; Sriteja Dixith; Daniel Vanzant; Jayne Kim; Jennifer L Dickerson; Soma Datta; Heather Powell; Sashwati Roy; Valerie Bergdall; Chandan K Sen
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

8.  S-allylcysteine Improves Blood Flow Recovery and Prevents Ischemic Injury by Augmenting Neovasculogenesis.

Authors:  Jia-Ning Syu; Mei-Due Yang; Shu-Yao Tsai; En-Pei Isabel Chiang; Shao-Chih Chiu; Che-Yi Chao; Raymond L Rodriguez; Feng-Yao Tang
Journal:  Cell Transplant       Date:  2017-10       Impact factor: 4.064

9.  Concave pit-containing scaffold surfaces improve stem cell-derived osteoblast performance and lead to significant bone tissue formation.

Authors:  Antonio Graziano; Riccardo d'Aquino; Maria Gabriella Cusella-De Angelis; Gregorio Laino; Adriano Piattelli; Maurizio Pacifici; Alfredo De Rosa; Gianpaolo Papaccio
Journal:  PLoS One       Date:  2007-06-06       Impact factor: 3.240

10.  Human mesenchymal stromal/stem cells recruit resident pericytes and induce blood vessels maturation to repair experimental spinal cord injury in rats.

Authors:  Karla Menezes; Barbara Gomes Rosa; Catarina Freitas; Aline Silva da Cruz; Raphael de Siqueira Santos; Marcos Assis Nascimento; Daiana Vieira Lopes Alves; Martin Bonamino; Maria Isabel Rossi; Radovan Borojevic; Tatiana Coelho-Sampaio
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.